New Key Statistics Module, Z-Score and F-Score
OTCPK:BPMUF Key Ratios
| Market Cap $ M | 576.24 |
| Enterprise Value $ M | 653.92 |
| P/E(ttm) | 77.91 |
| PE Ratio without NRI | 77.91 |
| Forward PE Ratio | 21.41 |
| Price/Book | -- |
| Price/Sales | 3.87 |
| Price/Free Cash Flow | 54.35 |
| Price/Owner Earnings | 107.71 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 178.00 |
| EPS (TTM) $ | 0.62 |
| Beneish M-Score | -3.03 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -0.80 |
| EV-to-EBIT | 28.02 |
| EV-to-EBITDA | 26.02 |
| PEG | -- |
| Shares Outstanding M | 12.00 |
| Net Margin (%) | 6.63 |
| Operating Margin % | 13.90 |
| Pre-tax Margin (%) | 6.64 |
| Quick Ratio | 2.64 |
| Current Ratio | 3.20 |
| ROA % (ttm) | 5.02 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | 17.22 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.32 |
BPMUF Number of Guru Trades
BPMUF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BPMUF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BPMUF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Basilea Pharmaceutica Ltd Insider Transactions
No Available Data
News about OTCPK:BPMUF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers